Drugs / TURCOVAC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04942405 | Jun 2021 → Mar 2023 | COVID-19 | Health Institutes of Turkey | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TURCOVAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04942405 ↗ |
| Modality | Vaccine | “experimental SARS-CoV-2 inactivated vaccine” NCT04942405 ↗ |
| Route | Intramuscular | “intramuscular injection” NCT04942405 ↗ |